In vivo application of chitosan to facilitate intestinal acyclovir absorption in rats

Ayumi Masuda, Yuko Goto, Yuji Kurosaki, Tetsuya Aiba

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

The effect of chitosan on the intestinal absorption of acyclovir (ACV) was evaluated in rats, and factors influencing its facilitative effect on the ACV absorption were examined. When ACV solution containing 1% chitosan with an average molecular weight of 150 kDa was administered into the upper jejunum, a significant increase in the plasma ACV concentration was observed, with the peak ACV concentration being eight times greater than that observed with the chitosan-free solution. The chitosan-free ACV solution, whose viscosity was adjusted to remain unchanged with polyethylene glycol, did not cause an increase in the plasma concentration, and neither did the chitosan-free solutions substitutionally containing low molecular cationic compounds, triethanolamine and kanamycin. When chitosan was digested with chitosanase to shorten its polycationic polysaccharide structure, chitosan subjected to 150-min digestion retained its facilitative effect on ACV absorption, but that subjected to 420-min digestion no longer caused facilitation, in which its average molecular weight was reduced to around 10 kDa. It is therefore indicated that intestinal ACV absorption can be facilitated with chitosan, and that it is necessary for chitosan to have a certain length of polycationic polysaccharide structure to exert such facilitation.

Original languageEnglish
Pages (from-to)2449-2456
Number of pages8
JournalJournal of Pharmaceutical Sciences
Volume101
Issue number7
DOIs
Publication statusPublished - Jul 2012

Fingerprint

Acyclovir
Intestinal Absorption
Chitosan
chitosanase
Polysaccharides
Digestion
Molecular Weight
Kanamycin
Jejunum
Viscosity

Keywords

  • Absorption enhancer
  • Acyclovir
  • Bioavailability
  • Chitosan
  • Chitosanase
  • Intestinal absorption
  • Polycation
  • Viscosity

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

In vivo application of chitosan to facilitate intestinal acyclovir absorption in rats. / Masuda, Ayumi; Goto, Yuko; Kurosaki, Yuji; Aiba, Tetsuya.

In: Journal of Pharmaceutical Sciences, Vol. 101, No. 7, 07.2012, p. 2449-2456.

Research output: Contribution to journalArticle

@article{18f21028448644ec86cc6af57068d5d0,
title = "In vivo application of chitosan to facilitate intestinal acyclovir absorption in rats",
abstract = "The effect of chitosan on the intestinal absorption of acyclovir (ACV) was evaluated in rats, and factors influencing its facilitative effect on the ACV absorption were examined. When ACV solution containing 1{\%} chitosan with an average molecular weight of 150 kDa was administered into the upper jejunum, a significant increase in the plasma ACV concentration was observed, with the peak ACV concentration being eight times greater than that observed with the chitosan-free solution. The chitosan-free ACV solution, whose viscosity was adjusted to remain unchanged with polyethylene glycol, did not cause an increase in the plasma concentration, and neither did the chitosan-free solutions substitutionally containing low molecular cationic compounds, triethanolamine and kanamycin. When chitosan was digested with chitosanase to shorten its polycationic polysaccharide structure, chitosan subjected to 150-min digestion retained its facilitative effect on ACV absorption, but that subjected to 420-min digestion no longer caused facilitation, in which its average molecular weight was reduced to around 10 kDa. It is therefore indicated that intestinal ACV absorption can be facilitated with chitosan, and that it is necessary for chitosan to have a certain length of polycationic polysaccharide structure to exert such facilitation.",
keywords = "Absorption enhancer, Acyclovir, Bioavailability, Chitosan, Chitosanase, Intestinal absorption, Polycation, Viscosity",
author = "Ayumi Masuda and Yuko Goto and Yuji Kurosaki and Tetsuya Aiba",
year = "2012",
month = "7",
doi = "10.1002/jps.23170",
language = "English",
volume = "101",
pages = "2449--2456",
journal = "Journal of Pharmaceutical Sciences",
issn = "0022-3549",
publisher = "John Wiley and Sons Inc.",
number = "7",

}

TY - JOUR

T1 - In vivo application of chitosan to facilitate intestinal acyclovir absorption in rats

AU - Masuda, Ayumi

AU - Goto, Yuko

AU - Kurosaki, Yuji

AU - Aiba, Tetsuya

PY - 2012/7

Y1 - 2012/7

N2 - The effect of chitosan on the intestinal absorption of acyclovir (ACV) was evaluated in rats, and factors influencing its facilitative effect on the ACV absorption were examined. When ACV solution containing 1% chitosan with an average molecular weight of 150 kDa was administered into the upper jejunum, a significant increase in the plasma ACV concentration was observed, with the peak ACV concentration being eight times greater than that observed with the chitosan-free solution. The chitosan-free ACV solution, whose viscosity was adjusted to remain unchanged with polyethylene glycol, did not cause an increase in the plasma concentration, and neither did the chitosan-free solutions substitutionally containing low molecular cationic compounds, triethanolamine and kanamycin. When chitosan was digested with chitosanase to shorten its polycationic polysaccharide structure, chitosan subjected to 150-min digestion retained its facilitative effect on ACV absorption, but that subjected to 420-min digestion no longer caused facilitation, in which its average molecular weight was reduced to around 10 kDa. It is therefore indicated that intestinal ACV absorption can be facilitated with chitosan, and that it is necessary for chitosan to have a certain length of polycationic polysaccharide structure to exert such facilitation.

AB - The effect of chitosan on the intestinal absorption of acyclovir (ACV) was evaluated in rats, and factors influencing its facilitative effect on the ACV absorption were examined. When ACV solution containing 1% chitosan with an average molecular weight of 150 kDa was administered into the upper jejunum, a significant increase in the plasma ACV concentration was observed, with the peak ACV concentration being eight times greater than that observed with the chitosan-free solution. The chitosan-free ACV solution, whose viscosity was adjusted to remain unchanged with polyethylene glycol, did not cause an increase in the plasma concentration, and neither did the chitosan-free solutions substitutionally containing low molecular cationic compounds, triethanolamine and kanamycin. When chitosan was digested with chitosanase to shorten its polycationic polysaccharide structure, chitosan subjected to 150-min digestion retained its facilitative effect on ACV absorption, but that subjected to 420-min digestion no longer caused facilitation, in which its average molecular weight was reduced to around 10 kDa. It is therefore indicated that intestinal ACV absorption can be facilitated with chitosan, and that it is necessary for chitosan to have a certain length of polycationic polysaccharide structure to exert such facilitation.

KW - Absorption enhancer

KW - Acyclovir

KW - Bioavailability

KW - Chitosan

KW - Chitosanase

KW - Intestinal absorption

KW - Polycation

KW - Viscosity

UR - http://www.scopus.com/inward/record.url?scp=84866300854&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84866300854&partnerID=8YFLogxK

U2 - 10.1002/jps.23170

DO - 10.1002/jps.23170

M3 - Article

C2 - 22535511

AN - SCOPUS:84866300854

VL - 101

SP - 2449

EP - 2456

JO - Journal of Pharmaceutical Sciences

JF - Journal of Pharmaceutical Sciences

SN - 0022-3549

IS - 7

ER -